Načítá se...
Biophysical Differences between Chronic Myelogenous Leukemic Quiescent and Proliferating Stem/Progenitor Cells
The treatment of chronic myeloid leukemia (CML), a clonal myeloproliferative disorder has improved recently, but most patients have not yet been cured. Some patients develop resistance to the available tyrosine kinase treatments. Persistence of residual quiescent CML stem cells (LSC) that later resu...
Uloženo v:
| Vydáno v: | Nanomedicine |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5116407/ https://ncbi.nlm.nih.gov/pubmed/27431055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2016.06.016 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|